Shelley A. Johns, Psy.D, ABPP

Shelley A. Johns, Psy.D, ABPP photo

Affiliate Faculty

Shelley A. Johns, Psy.D., ABPP.  Shelley is a Board Certified Clinical Health Psychologist, an Assistant Professor of Medicine at Indiana University School of Medicine and a Research Scientist with Regenstrief Institute.  Shelley recently completed her time with FCME as the Walther Scholar, where she did amazing work conducting a behavioral intervention trial with Paul Helft, entitled “Mindfully Optimizing Delivery of End-of-Life Care (MODEL Care): Feasibility of a Synergistic Intervention for Patients, Family Caregivers, and Providers.” The MODEL Care intervention was developed to address the avoidant coping that often inhibits timely end-of-life discussions and advance care planning for adults with advanced-stage cancer. They trained patients and their family caregivers and oncologists in present-centered awareness and non-reactive coping through mindfulness meditation practices with the aim that all parties would be able to approach these tender conversations with greater ease.  Her patient-oriented research primarily focuses on testing integrative mind-body interventions to reduce cancer-related fatigue and associated symptoms for post-treatment cancer survivors and improving adaptive coping and quality of life for adults with advanced-stage cancer and their family caregivers.

Education

  • Indiana State University, B.S. Journalism and Radio-TV-Film
  • Indiana State University, B.S. Psychology
  • Indiana State University, M.S. Psychology
  • Indiana State University, Psy.D. Clinical Psychology
  • Indiana University School of Nursing, Postdoctorate, Behavioral Oncology
  • Indiana University Health Fairbanks Center for Medical Ethics Fellowship
  • City of Hope Transdisciplinary Palliative Care
  • West Virginia University School of Medicine Pre-doctoral Clinical Internship

Representative Publications

  • Carpenter, J. S., Storniolo, A. M., Johns, S., Monahan, P. O., Azzouz, F., Elam, J. L., & Shelton, R. C. (2007). Randomized, double blind, placebo-controlled, crossover trials of venlafaxine for hot flashes in breast cancer survivors. Oncologist, 12(1):124-135. PMID: 17227907

    Click here to view. 

  • Carpenter, J. S., Yu, M., Wu, J., Von Ah, D., Milata, J., Otte, J. L., Johns, S., Schneider, B., Storniolo, A. M., Salomon, R., Desta, Z., Cao, J., Jin, Y., Philips, S., & Skaar, T. (2009). Evaluating the role of serotonin in hot flashes after breast cancer using acute tryptophan depletion. Menopause, 16(4):644-652. PMID: 19265726

    Click here to view. 

  • Johns, S.A., Kroenke, K., Theobald, D., Wu, J., & Tu, W. (2011). Telecare management of pain and depression in patients with cancer: Patient satisfaction and predictors of use. Journal of Ambulatory Care Management, 34(2):126-139. PMID: 21415611

    Click here to view.